Our study sought to delineate the molecular underpinnings of BCc1's anti-tumor effects in a BALB/c murine model of BC, focusing on key autophagy regulators (Beclin-1, ATG-4B, ATG-7) and the mTOR signaling axis. The gene discussed is BECN1; the disease is breast cancer.